Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels (Q44522392)

3 December 2017

title

Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels (English)

1 reference

3 December 2017

0 references

6

1 reference

3 December 2017

Steen Bendix Haugaard

object named as

Steen B Haugaard

4

0 references

Ove Andersen

object named as

Ove Andersen

7

0 references

Steen B. Pedersen

3

object named as

Steen B Pedersen

1 reference

3 December 2017

Aina S Lihn

1

1 reference

3 December 2017

Bjørn Richelsen

2

1 reference

3 December 2017

Gulla Søby Rathje

5

1 reference

3 December 2017

publication date

22 July 2003

1 reference

American Journal of Physiology - Endocrinology and Metabolism

3 December 2017

published in

1 reference

3 December 2017

volume

285

1 reference

3 December 2017

issue

5

1 reference

3 December 2017

page(s)

E1072-80

1 reference

Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Chemokines in pathology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

The role of the novel adipocyte-derived hormone adiponectin in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Association between adiponectin and mediators of inflammation in obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Serum adiponectin and leptin levels in patients with lipodystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Mechanisms of TNF-alpha-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Regulation of leptin by steroid hormones in rat adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Adiponectin and development of type 2 diabetes in the Pima Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Interleukin-6 induces cellular insulin resistance in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Regional fat deposition in the legs is useful as a presumptive marker of antiatherogenesity in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Contributions of total and regional fat mass to risk for cardiovascular disease in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome—an analysis by structural equation modelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00206.2003

10.1152/AJPENDO.00206.2003

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference